Gilder Gagnon Howe & Co’s Hinge Health HNGE Stock Holding History
Bought
Maintained
Sold
Other funds holding HNGE
IHG
12CM
DMC
BC
RI
ACH
B
VPM
Gilder Gagnon Howe & Co's HNGE Position: Q1 2026 in Review
Gilder Gagnon Howe & Co reduced its Hinge Health (HNGE) stake by 26% in Q1 2026, selling an estimated $2.15M and leaving 150,549 shares worth $5.81M. The position accounts for 0.07% of the portfolio, ranked #141.
Gilder Gagnon Howe & Co first reported a position in HNGE in Q2 2025 and has held it in 4 quarters since. The position peaked at $10.1M in Q3 2025. 203 funds tracked by Wall St. Rank hold HNGE as of Q1 2026.
- Gilder Gagnon Howe & Co held 150,549 shares of Hinge Health worth $5.81M as of Q1 2026.
- Gilder Gagnon Howe & Co sold 51,663 Hinge Health shares in Q1 2026, an estimated $2.15M.
- Hinge Health made up 0.07% of Gilder Gagnon Howe & Co's portfolio in Q1 2026, its #141 holding.
- Gilder Gagnon Howe & Co first reported a position in Hinge Health in Q2 2025 and has held it in 4 quarters since.
- Gilder Gagnon Howe & Co's Hinge Health position peaked at $10.1M in Q3 2025.
- 203 funds tracked by Wall St. Rank held Hinge Health as of Q1 2026.
Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2026, filed 15 May 2026.